Nervecentre wins place on all-Wales ePMA framework agreement

Nervecentre Software program Ltd has been awarded a spot on a framework settlement with Digital Well being and Care Wales which can see it present an digital platform for prescriptions, medicines reconciliation and administration.

The platform might be utilized in hospitals throughout the nation. It not solely saves clinicians time when prescribing and administering medicines, however it additionally improves affected person security.

The answer may also help to minimise dangers of remedy errors, whereas additionally enabling scientific choice help to make sure excessive ranges of affected person care.

Paul Volkaerts, CEO at Nervecentre Software program Ltd, stated: “We’re delighted to be awarded a spot on the Welsh ePMA framework, and we stay up for working along with hospitals and well being boards in Wales to introduce this complete ePrescribing programme, serving to to make the prescribing, dishing out and administration of medicines all over the place in Wales, simpler, safer, extra environment friendly and efficient.”

Nervecentre is one in every of three organisations which might be included on the all-Wales ePMA framework. In the course of the tender course of it was ranked in first place, reaching full marks for its scientific capabilities.

Nervecentre’s closed-loop e-prescribing and barcode remedy administration software program (ePMA) is used extensively throughout 4 NHS acute trusts in England.

These trusts embody: University Hospitals of Leicester NHS Trust; Bedfordshire Hospitals NHS Basis Belief; Sherwood Forest Hospitals NHS Foundation Trust; and Nottingham College Hospitals NHS Belief.

The ePMA is utilized in in-patients, maternity, paediatrics and emergency departments, with Nervecentre estimating one million medicines a month are prescribed utilizing its ePMA answer.

As well as, it believes as many as 99% of these are administered on the affected person’s bedside utilizing an app. The ePMA answer offers full validation in opposition to allergic reactions and drug-drug interactions, even when utilized in cellular kind.

The inclusion of Nervecentre on the all-Wales ePMA framework follows on from the all-Wales Hospital Pharmacy system, which was applied in 2020 as a part of plans to modernise pharmacy and prescribing.